tiprankstipranks
Trending News
More News >
Ausnutria Dairy Corp. Ltd. (HK:1717)
:1717
Hong Kong Market

Ausnutria Dairy Corp. Ltd. (1717) AI Stock Analysis

Compare
3 Followers

Top Page

HK:1717

Ausnutria Dairy Corp. Ltd.

(1717)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 4o)
Rating:59Neutral
Price Target:
HK$2.00
â–¼(-4.31% Downside)
The overall stock score is primarily influenced by the company's stable financial position and reasonable valuation. However, bearish technical indicators and challenges in cash flow management weigh down the score. The lack of growth initiatives and liquidity concerns are significant risks.
Positive Factors
Strong Equity Position
A conservative leverage ratio indicates financial stability, providing the company with flexibility to invest in growth opportunities without excessive debt burden.
Improved Profitability Margins
Improved profitability margins suggest effective cost management and operational efficiency, enhancing the company's ability to generate profits from its operations.
Global Market Presence
A strong global market presence diversifies revenue streams and reduces dependency on any single market, providing resilience against regional economic fluctuations.
Negative Factors
Stagnant Revenue Growth
Stagnant revenue growth suggests potential challenges in market expansion or product demand, necessitating strategic initiatives to drive future growth.
Negative Free Cash Flow
Negative free cash flow indicates that capital expenditures are not being matched by operational inflows, potentially affecting long-term cash sustainability and investment capacity.
Low Operational Efficiency
Low operational efficiency margins suggest that the company may need to optimize its operations to improve profitability and competitiveness in the market.

Ausnutria Dairy Corp. Ltd. (1717) vs. iShares MSCI Hong Kong ETF (EWH)

Ausnutria Dairy Corp. Ltd. Business Overview & Revenue Model

Company DescriptionAusnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, milk collection, processing, production, packaging, marketing, and distribution of infant formula and other dairy products. The company operates in two segments, Dairy and Related Products, and Nutrition Products. It offers cow milk-based formula products under the Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo brand names; and goat milk-based infant formula products under the Kabrita brand. The company also produces formula milk powder products on an original equipment manufacturing basis. In addition, it engages in the manufacturing and distribution of nutrition products; development, distribution, and sale of probiotic products; and provision of financing services. The company operates in the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and internationally. The company was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
How the Company Makes MoneyAusnutria Dairy Corp. Ltd. generates revenue primarily through the sale of its dairy products, with a significant focus on infant formula, which is a highly profitable segment in the dairy industry. The company employs a multi-channel distribution strategy, supplying products through both online and offline retail platforms. Key revenue streams include sales from domestic markets and exports to international markets, particularly in regions with high demand for premium dairy products. Ausnutria also benefits from strategic partnerships with various retailers and distributors, which enhance its market reach. Additionally, the company invests in brand development and marketing to strengthen its market presence and drive consumer loyalty, ultimately contributing to its earnings.

Ausnutria Dairy Corp. Ltd. Financial Statement Overview

Summary
The company has a stable financial position with strong equity and improved profitability margins. However, challenges in cash flow management and stagnant revenue growth indicate a need for strategic initiatives to enhance operational efficiency and liquidity.
Income Statement
75
Positive
The company has shown consistent revenue generation with a slight increase in 2024 compared to previous years. Gross Profit Margin remained strong at 41.98% in 2024, reflecting a good cost management strategy. Net Profit Margin improved to 3.19% in 2024 from 2.36% in 2023, indicating enhanced profitability. However, EBIT Margin and EBITDA Margin are relatively low at 5.16% and 8.71% respectively, suggesting operational efficiency could be improved. The revenue growth has been stagnant, indicating a need for strategic growth initiatives.
Balance Sheet
70
Positive
The balance sheet shows a stable position with a Debt-to-Equity Ratio of 0.39, suggesting conservative leverage. Return on Equity (ROE) is relatively low at 4.12% in 2024, indicating modest returns to shareholders. The Equity Ratio remains strong at 59.23%, highlighting a solid capital structure with a significant proportion of assets financed by equity. The company has maintained a healthy cash reserve, although there is a slight decline in cash and cash equivalents over the years, which might restrict liquidity.
Cash Flow
60
Neutral
The cash flow position is mixed, with Operating Cash Flow to Net Income Ratio of 1.27 in 2024, indicating good cash conversion. However, Free Cash Flow has been negative, reflecting high capital expenditures that have not been matched by operational inflows, potentially affecting long-term cash sustainability. The Free Cash Flow to Net Income Ratio is negative, signaling concerns over cash efficiency and capital expenditure management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.66B7.40B7.38B7.80B8.58B7.99B
Gross Profit2.32B3.11B2.85B3.39B4.15B3.98B
EBITDA513.11M645.26M503.39M529.50M1.26B1.50B
Net Income180.81M235.97M174.39M216.53M763.79M1.00B
Balance Sheet
Total Assets10.50B9.66B10.03B9.80B9.51B9.25B
Cash, Cash Equivalents and Short-Term Investments1.01B1.42B2.04B1.87B2.26B1.86B
Total Debt2.73B2.25B2.42B1.56B1.30B1.09B
Total Liabilities4.31B3.88B4.28B4.23B4.02B4.10B
Stockholders Equity6.13B5.72B5.69B5.65B5.54B5.17B
Cash Flow
Free Cash Flow-168.74M-86.32M-459.31M-1.06B514.93M623.59M
Operating Cash Flow92.45M299.37M224.71M-357.54M1.07B1.13B
Investing Cash Flow-770.46M-899.16M-740.92M-723.98M-606.57M-402.58M
Financing Cash Flow-325.59M-273.59M682.45M664.11M-34.09M-494.87M

Ausnutria Dairy Corp. Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.09
Price Trends
50DMA
2.22
Negative
100DMA
2.38
Negative
200DMA
2.20
Negative
Market Momentum
MACD
-0.02
Positive
RSI
39.31
Neutral
STOCH
13.19
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1717, the sentiment is Negative. The current price of 2.09 is below the 20-day moving average (MA) of 2.17, below the 50-day MA of 2.22, and below the 200-day MA of 2.20, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 39.31 is Neutral, neither overbought nor oversold. The STOCH value of 13.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1717.

Ausnutria Dairy Corp. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
HK$57.01B12.6024.70%3.34%2.03%1.43%
66
Neutral
HK$25.92B19.4818.11%4.83%23.90%10.72%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
59
Neutral
HK$3.75B12.854.53%2.83%0.52%99.51%
58
Neutral
HK$6.70B28.917.63%2.21%-3.39%91.63%
56
Neutral
HK$58.71B-180.14-0.74%3.65%-7.36%-107.25%
55
Neutral
HK$36.50B12.5410.48%6.98%-0.64%-24.62%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1717
Ausnutria Dairy Corp. Ltd.
2.09
0.26
14.21%
HK:0151
Want Want China Holdings
4.86
0.48
10.93%
HK:2319
China Mengniu Dairy Co
15.24
-1.86
-10.87%
HK:0345
Vitasoy International Holdings
6.39
-4.05
-38.78%
HK:9985
Weilong Delicious Global Holdings Limited
10.57
3.53
50.14%
HK:6186
China Feihe Limited
4.06
-1.14
-21.92%

Ausnutria Dairy Corp. Ltd. Corporate Events

Ausnutria Dairy Clarifies Probiotics Supply Agreement Caps
Nov 4, 2025

Ausnutria Dairy Corporation Ltd announced a clarification regarding its Probiotics Supply Framework Agreement, specifying the annual transaction caps for the financial years ending in 2025, 2026, and 2027. The caps are set at RMB10 million, RMB40 million, and RMB65 million, respectively, indicating a significant increase over the period, which may impact the company’s market positioning and operations.

Ausnutria Dairy Signs Probiotics Supply Agreement with Yili Industrial
Oct 31, 2025

Ausnutria Dairy Corporation Ltd. has entered into a Probiotics Supply Framework Agreement with Yili Industrial, a controlling shareholder, to supply probiotics and related products until December 2027. This agreement, classified as a continuing connected transaction under Hong Kong’s Listing Rules, does not require independent shareholders’ approval but is subject to reporting and annual review requirements, indicating a strategic partnership that could enhance Ausnutria’s market positioning and operational scope.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 04, 2025